These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30372021)

  • 21. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes.
    Zambrano P; Suwalsky M; Jemiola-Rzeminska M; Strzalka K; Sepúlveda B; Gallardo MJ; Aguilar LF
    Biochim Biophys Acta Biomembr; 2019 Jun; 1861(6):1078-1085. PubMed ID: 30904408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid pharmacophore design and synthesis of donepezil-inspired aurone derivative salts as multifunctional acetylcholinesterase inhibitors.
    Funahashi R; Matsuura F; Ninomiya M; Okabe S; Takashima S; Tanaka K; Nishina A; Koketsu M
    Bioorg Chem; 2024 Apr; 145():107229. PubMed ID: 38401360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
    Sahin Z; Ertas M; Bender C; Bülbül EF; Berk B; Biltekin SN; Yurttaş L; Demirayak Ş
    Drug Dev Res; 2018 Dec; 79(8):406-425. PubMed ID: 30343499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Donepezil Reduces Amyloid Precursor Protein Endocytosis by Resulting from Increase in the Expression of Sorting Nexin Protein 33].
    Takada-Takatori Y
    Yakugaku Zasshi; 2021; 141(6):851-856. PubMed ID: 34078793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression.
    Li X; Li J; Huang Y; Gong Q; Fu Y; Xu Y; Huang J; You H; Zhang D; Zhang D; Mao F; Zhu J; Wang H; Zhang H; Li J
    Eur J Med Chem; 2022 Feb; 229():114045. PubMed ID: 34922191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation.
    Damuka N; Kammari K; Potshangbam AM; Rathore RS; Kondapi AK; Vindal V
    Pharmacol Rep; 2020 Jun; 72(3):705-718. PubMed ID: 32200493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of new oxopyrrolidine derivatives as inhibitors of acetyl cholinesterase and β amyloid protein as anti - Alzheimer's agents.
    Mohamed LW; Abuel-Maaty SM; Mohammed WA; Galal MA
    Bioorg Chem; 2018 Feb; 76():210-217. PubMed ID: 29190477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.
    Costa M; Josselin R; Silva DF; Cardoso SM; May NV; Chaves S; Santos MA
    J Inorg Biochem; 2020 May; 206():111039. PubMed ID: 32171933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donepezil-Inspired Multitargeting Indanone Derivatives as Effective Anti-Alzheimer's Agents.
    Singh JV; Thakur S; Kumar N; Singh H; Mithu VS; Singh H; Bhagat K; Gulati HK; Sharma A; Singh H; Sharma S; Bedi PMS
    ACS Chem Neurosci; 2022 Mar; 13(6):733-750. PubMed ID: 35195392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Ezzat MAF; Abdelhamid SM; Fouad MA; Abdel-Aziz HA; Allam HA
    Drug Dev Res; 2023 Sep; 84(6):1231-1246. PubMed ID: 37243322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a New Donepezil-like Acetylcholinesterase Inhibitor for Targeting Alzheimer's Disease: Computational Studies with Biological Validation.
    Akhoon BA; Choudhary S; Tiwari H; Kumar A; Barik MR; Rathor L; Pandey R; Nargotra A
    J Chem Inf Model; 2020 Oct; 60(10):4717-4729. PubMed ID: 32955256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    Girgin M; Isik S; Kantarci-Carsibasi N
    PLoS One; 2023; 18(4):e0284994. PubMed ID: 37104478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Deoxyvasicinone-Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer's Disease.
    Du H; Liu X; Xie J; Ma F
    ACS Chem Neurosci; 2019 May; 10(5):2397-2407. PubMed ID: 30720268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor.
    Sugimoto H; Ogura H; Arai Y; Limura Y; Yamanishi Y
    Jpn J Pharmacol; 2002 May; 89(1):7-20. PubMed ID: 12083745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.
    Abe Y; Aoyagi A; Hara T; Abe K; Yamazaki R; Kumagae Y; Naruto S; Koyama K; Marumoto S; Tago K; Toda N; Takami K; Yamada N; Ori M; Kogen H; Kaneko T
    J Pharmacol Sci; 2003 Sep; 93(1):95-105. PubMed ID: 14501158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donepezil-melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments.
    Łozińska I; Świerczyńska A; Molęda Z; Hartman AM; Hirsch AKH; Czarnocki Z
    Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800194. PubMed ID: 30290008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase as a Target for Drug Development in Alzheimer's Disease.
    Sharma P; Tripathi MK; Shrivastava SK
    Methods Mol Biol; 2020; 2089():257-286. PubMed ID: 31773661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.
    Sugimoto H; Yamanishi Y; Iimura Y; Kawakami Y
    Curr Med Chem; 2000 Mar; 7(3):303-39. PubMed ID: 10637367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholinesterase inhibition in Alzheimer's Disease.
    Ibach B; Haen E
    Curr Pharm Des; 2004; 10(3):231-51. PubMed ID: 14754384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.